ARTICLE | Company News
Sequenom sales and marketing update
February 11, 2013 8:00 AM UTC
Sequenom said it expanded the range of chromosomal abnormalities reported by the MaterniT21 Plus laboratory-developed test (LDT) to include fetal sex chromosomal aneuploidies, including Turner's synd...